Published in Diabetes Care on January 22, 2013
Strategies to Enhance New CGM Use in Early Childhood (SENCE) (SENCE) | NCT02912728
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med (2014) 3.38
Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care (2014) 2.53
Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med (2015) 1.75
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol (2016) 1.59
Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes (2015) 1.46
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care (2015) 1.36
Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes (2013) 1.31
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab (2014) 1.29
Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep (2013) 1.09
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial. Diabetes Care (2016) 1.03
Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications. Curr Med Chem (2013) 1.03
Clinical review: Diabetes in the adolescent: transitional issues. J Clin Endocrinol Metab (2013) 1.00
Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes (2014) 0.98
Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. Diabetes Technol Ther (2016) 0.96
Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study. Pediatr Diabetes (2014) 0.93
Challenges and future directions of the T1D Exchange Clinic Network and registry. J Diabetes Sci Technol (2013) 0.92
Features of online health communities for adolescents with type 1 diabetes. West J Nurs Res (2014) 0.91
Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes (2015) 0.88
Cardiovascular health in adolescents with type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes (2014) 0.87
A review of adolescent adherence in type 1 diabetes and the untapped potential of diabetes providers to improve outcomes. Curr Diab Rep (2015) 0.87
A novel approach to adolescents with type 1 diabetes: the team clinic model. Diabetes Spectr (2015) 0.85
Staying Positive: Positive Affect as a Predictor of Resilience in Adolescents With Type 1 Diabetes. J Pediatr Psychol (2015) 0.84
Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep (2014) 0.83
Associations of nutrient intake with glycemic control in youth with type 1 diabetes: differences by insulin regimen. Diabetes Technol Ther (2014) 0.82
Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment. PLoS One (2013) 0.82
Developmental changes in the roles of patients and families in type 1 diabetes management. Curr Diabetes Rev (2015) 0.81
Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract (2014) 0.80
Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond. Curr Diab Rep (2015) 0.80
Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Suboptimally Controlled Adolescents With Type 1 Diabetes: A 3-Week, Free-Living, Randomized Crossover Trial. Diabetes Care (2016) 0.80
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes. PLoS One (2015) 0.80
Contribution of income to self-management and health outcomes in pediatric type 1 diabetes. Pediatr Diabetes (2014) 0.79
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes. Pediatr Diabetes (2016) 0.79
Text messaging intervention for teens and young adults with diabetes. J Diabetes Sci Technol (2014) 0.79
Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. Diabetes Technol Ther (2017) 0.79
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet (2016) 0.78
New approaches to providing individualized diabetes care in the 21st century. Curr Diabetes Rev (2015) 0.78
Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes (2013) 0.78
Care utilization in a pediatric diabetes clinic: cancellations, parental attendance, and mental health appointments. J Pediatr (2014) 0.78
Persistently high glucose levels in young children with type 1 diabetes. Pediatr Diabetes (2014) 0.78
Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial. Diabetes Obes Metab (2015) 0.78
Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes. Diabetes Care (2014) 0.77
Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults. Diabetes Educ (2014) 0.77
Use of Commonly Available Technologies for Diabetes Information and Self-Management Among Adolescents With Type 1 Diabetes and Their Parents: A Web-Based Survey Study. Interact J Med Res (2015) 0.77
Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes. J Diabetes Sci Technol (2014) 0.77
Lipoprotein subfraction cholesterol distribution is more atherogenic in insulin resistant adolescents with type 1 diabetes. Pediatr Diabetes (2015) 0.77
Changes in diet and physical activity in adolescents with and without type 1 diabetes over time. Int J Pediatr Endocrinol (2014) 0.76
Efficacy and implementation of an Internet psychoeducational program for teens with type 1 diabetes. Pediatr Diabetes (2015) 0.76
Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes. Acta Diabetol (2014) 0.76
Trajectories of HbA1c levels in children and youth with type 1 diabetes. PLoS One (2014) 0.75
Challenges in Delivering Smaller Doses of Insulin. Diabetes Technol Ther (2015) 0.75
Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes (2016) 0.75
Texting Adolescents in Repeat DKA and Their Caregivers. J Diabetes Sci Technol (2016) 0.75
An Audit of Clinical Practice in a Single Centre in Kuwait: Management of Children on Continuous Subcutaneous Insulin Infusion and Cardiovascular Risk Factors Screening. Open Cardiovasc Med J (2017) 0.75
Youth-Perceived Burden of Type 1 Diabetes: Problem Areas in Diabetes Survey-Pediatric Version (PAID-Peds). J Diabetes Sci Technol (2015) 0.75
The Future of Glucose Monitoring. Diabetes Technol Ther (2016) 0.75
The Feasibility of a Pilot Intervention for Parents of Young Children Newly Diagnosed with Type 1 Diabetes. Clin Pract Pediatr Psychol (2016) 0.75
Biopsychosocial pathways linking subjective socioeconomic disadvantage to glycemic control in youths with type I diabetes. Psychoneuroendocrinology (2017) 0.75
Maternal diabetes distress is linked to maternal depressive symptoms and adolescents' glycemic control. Pediatr Diabetes (2015) 0.75
Will the First Approved Automated Insulin Delivery System Be a Game-Changer in Type 1 Diabetes Management? Diabetes Technol Ther (2017) 0.75
6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia. Diabetes Technol Ther (2013) 0.75
Flexible Lifestyles for Youth (FL3X) behavioural intervention for at-risk adolescents with Type 1 diabetes: a randomized pilot and feasibility trial. Diabet Med (2014) 0.75
A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial. JMIR Mhealth Uhealth (2017) 0.75
General and diabetes-specific stress in adolescents with type 1 diabetes. Diabetes Res Clin Pract (2017) 0.75
Team Clinic: An Innovative Group Care Model for Youth with Type 1 Diabetes-Engaging Patients and Meeting Educational Needs. J Nurse Pract (2017) 0.75
Outcomes associated with a pediatric clinical diabetes network in Ontario: a population-based time-trend analysis. CMAJ Open (2017) 0.75
CoYoT1 Clinic: Innovative Telemedicine Care Model for Young Adults with Type 1 Diabetes. Diabetes Technol Ther (2016) 0.75
Diabetes care provider perceptions on family challenges of pediatric type 1 diabetes. Diabetes Res Clin Pract (2017) 0.75
Design and development of a stepped-care behavioral intervention to support parents of young children newly diagnosed with type 1 diabetes. Contemp Clin Trials (2017) 0.75
An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child (2017) 0.75
Stress and Posttraumatic Stress in Mothers of Children With Type 1 Diabetes. J Fam Nurs (2017) 0.75
Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus. Pak J Med Sci (2017) 0.75
Delay discounting and parental monitoring in adolescents with poorly controlled type 1 diabetes. J Behav Med (2017) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
The T1D Exchange clinic registry. J Clin Endocrinol Metab (2012) 3.45
Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes (2009) 2.15
Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr (2010) 2.05
Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care (2003) 2.01
Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care (2003) 1.41
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes (2007) 1.39
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia (2005) 1.33
Impact of physical activity on cardiovascular risk factors in children with type 1 diabetes: a multicenter study of 23,251 patients. Diabetes Care (2007) 1.07
Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes? Diabetes Technol Ther (2012) 1.01
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med (2002) 11.32
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care (2008) 6.53
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol (2005) 4.38
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 4.30
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA (2007) 4.09
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
The T1D Exchange clinic registry. J Clin Endocrinol Metab (2012) 3.45
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet (2003) 3.31
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet (2011) 3.13
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care (2014) 2.83
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care (2015) 2.79
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes (2005) 2.64
Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab (2004) 2.61
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology (2007) 2.58
A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology (2006) 2.51
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet (2013) 2.45
Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab (2006) 2.34
Retinal nerve fiber layer thickness in amblyopic eyes. Am J Ophthalmol (2009) 2.29
A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol (2008) 2.26
A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care (2004) 2.20
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19
The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology (2008) 2.19
Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care (2002) 2.15
Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. Kidney Int (2010) 2.12
Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract (2011) 2.12
Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics (2011) 2.09
Predictors of changes in glucose tolerance status in obese youth. Diabetes Care (2005) 2.08
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care (2013) 2.03
Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 2.02
Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care (2007) 1.98
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology (2008) 1.94
Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab (2013) 1.92
Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr (2006) 1.90
Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther (2006) 1.89
Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. J AAPOS (2009) 1.89
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol (2008) 1.87
Assessing weight-related quality of life in adolescents. Obesity (Silver Spring) (2006) 1.85
Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study. Diabetes (2010) 1.80
Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol (2008) 1.80
Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes (2013) 1.78
Clinical profile and early surgical complications in the Cornea Donor Study. Cornea (2006) 1.77
Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old. Am J Ophthalmol (2003) 1.76
Participatory surveillance of hypoglycemia and harms in an online social network. JAMA Intern Med (2013) 1.76
Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther (2005) 1.75
Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technol Ther (2005) 1.74
The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab (2005) 1.74
Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes (2010) 1.73
A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther (2009) 1.73
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology (2007) 1.73
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. Arch Ophthalmol (2009) 1.72
Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes (2005) 1.70
Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther (2005) 1.70
Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care (2008) 1.69
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2011) 1.67
Specular microscopy ancillary study methods for donor endothelial cell density determination of Cornea Donor Study images. Curr Eye Res (2006) 1.65
Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol (2007) 1.64
Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes (2005) 1.64
Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care (2012) 1.63
Risk of amblyopia recurrence after cessation of treatment. J AAPOS (2004) 1.59
Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics (2015) 1.58